# Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization

> **NCT01183143** · PHASE3 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 215 (actual)

## Conditions studied

- Infertility
- Ovulation Induction
- In-Vitro Fertilization

## Interventions

- **DRUG:** GONAL-f®

## Key facts

- **NCT ID:** NCT01183143
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05-11
- **Primary completion:** 2006-03-02
- **Final completion:** 2006-03-02
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01183143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01183143, "Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01183143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*